Merck & Co. Segmentwise Revenues

Segmentwise Revenue of Merck and Co. 2015-2021

Amounts are in $millions.

Year Pharmaceutical Animal HealthOther  Total
2021$42,754$5,568$382$48,704
2020$36,610$4,703$205$41,518
2019$34,100$4,393$628$39,121
2018 $37,689 $4,212 $393 $ 42,294
2017 $35,390 $3,875 $857 $ 40,122
2016 $35,151 $2,287 $1,178 $ 39,807
2015 $34,782 $3,331 $1,385$39,498 

2021: The operations of Merck & Co are divided into two main segments including pharmaceutical and human health. The pharmaceutical segment includes human health pharmaceutical and vaccine products. In 2021, the company generated $42,754 million from the pharmaceutical segment compared to $36,610 million in 2020. Its net sales from the animal segment were $5,568 million in 2021 compared to $4,703 million in 2020. In 2021, a substantial part of the company's growth was driven by its oncology portfolio and mainly Keytruda, which accounted for $17.2 billion of the company's sales in 2021 compared to $14.4 billion in 2020.